Cleared Traditional

K102069 - JOURNEY UNICONDYLAR TIBIAL BASEPLATES

K102069 is the FDA 510(k) clearance for JOURNEY UNICONDYLAR TIBIAL BASEPLATES by Smith & Nephew, Inc.. It is a Class 2 Orthopedic device (product code HSX) cleared through the Traditional 510(k) pathway after a 74-day FDA review.

K102069 · Smith & Nephew, Inc. · Orthopedic device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 2010
Decision
74d
Days
Class 2
Risk

K102069 is an FDA 510(k) clearance for the JOURNEY UNICONDYLAR TIBIAL BASEPLATES. Classified as Prosthesis, Knee, Femorotibial, Non-constrained, Cemented, Metal/polymer (product code HSX), Class II - Special Controls.

Submitted by Smith & Nephew, Inc. (Memphis, US). The FDA issued a Cleared decision on October 5, 2010 after a review of 74 days - a notably fast clearance cycle.

This device falls under the Orthopedic FDA review panel, regulated under 21 CFR 888.3520 - the FDA orthopedic device regulatory framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Smith & Nephew, Inc. devices

Submission Details

510(k) Number K102069 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 23, 2010
Decision Date October 05, 2010
Days to Decision 74 days
Submission Type Traditional
Review Panel Orthopedic (OR)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
48d faster than avg
Panel avg: 122d · This submission: 74d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code HSX Prosthesis, Knee, Femorotibial, Non-constrained, Cemented, Metal/polymer
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 888.3520
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Orthopedic devices follow this clearance model.

Regulatory Peers - HSX Prosthesis, Knee, Femorotibial, Non-constrained, Cemented, Metal/polymer

All 99
Devices cleared under the same product code (HSX) and FDA review panel - the closest regulatory comparables to K102069.
ZIMMER PATIENT SPECIFIC INSTRUMENTS PLANNER
K112301 · Materialise NV · Jan 2012
SMITH & NEPHEW INC. UNICOMPARTMENTAL AND BIOCOMPARTMENTAL KNEE SYSTEM INSTRUMENTS
K113038 · Smith & Nephew, Inc. · Jan 2012
CONFORMIS IUNI UNICONDYLAR KNEE REPLACEMENT SYSTEM
K111916 · Conformis, Inc. · Sep 2011
GENESIS UNICONDYLAR UHMWPE ARTICULAR INSERTS
K100197 · Smith & Nephew, Inc. · Feb 2010
MODIFICATION TO: CONFORMIS IUNI UNICONDYLAR KNEE REPAIR SYSTEM
K092441 · Conformis, Inc. · Sep 2009
MAKO SURGICAL CORPORATION UNICONDYLAR KNEE IMPLANT SYSTEM III
K082081 · Mako Surgical Corp. · Oct 2008